Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 351 - 400 of 3,591
Importer of Controlled Substances Application: AndersonBrecon Inc. DBA PCI of Illinois
Document Number: 2019-10006
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl in Schedule I
Document Number: 2019-09479
Type: Rule
Date: 2019-05-08
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2- (thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide), also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl- propanamide, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This rule continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.
Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; Correction
Document Number: 2019-09477
Type: Rule
Date: 2019-05-08
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is correcting a final order that appeared in the Federal Register on November 29, 2018. The document issued an action maintaining the placement of furanyl fentanyl, 4-fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. A drafting oversight in the amendatory instructions did not correctly update the prefatory language on isomers to reflect the change in the paragraph number for the designation of 3-methylthiofentanyl.
Schedules of Controlled Substances: Temporary Placement of N
Document Number: 2019-08704
Type: Proposed Rule
Date: 2019-05-01
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule the synthetic cathinones, N-ethylhexedrone; alpha- pyrrolidinohexanophenone (trivial name: [alpha]-PHP); 4-methyl-alpha- ethylaminopentiophenone (trivial name: 4-MEAP); 4'-methyl-alpha- pyrrolidinohexiophenone (trivial name: MPHP); alpha- pyrrolidinoheptaphenone (trivial name: PV8); and 4-chloro-alpha- pyrrolidinovalerophenone (trivial name: 4-chloro-[alpha]-PVP), in schedule I. When it is issued, the temporary scheduling order will impose regulatory requirements under the Controlled Substances Act (CSA) on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, conduct of instructional activities, and chemical analysis of these synthetic cathinones, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.
Interlocutory Appeals in Administrative Hearings
Document Number: 2019-08705
Type: Rule
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is amending its hearing regulations to provide that, when the presiding officer of an administrative hearing denies an interlocutory appeal, he shall transmit his determination to the Drug Enforcement Administration Administrator for discretionary review.
Palafox Pharmacy; Decision and Order
Document Number: 2019-08703
Type: Notice
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.
Document Number: 2019-08702
Type: Notice
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
Chemical Names of Previously Controlled Fentanyl-Related Substances
Document Number: 2019-07457
Type: Rule
Date: 2019-04-19
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing additional descriptive information with respect to five specific substances already covered by a temporary scheduling order that appeared in the Federal Register on February 6, 2018. That order placed fentanyl-related substances temporarily in schedule I of the Controlled Substances Act. The order further stated that if and when DEA identifies a specific new substance that falls under the definition of a fentanyl-related substance, the agency will publish in the Federal Register, and on the agency website, the chemical name of such substance. Consistent therewith, this document provides the chemical names of five substances that fall within the definition of fentanyl- related substances that were temporarily controlled under the scheduling order issued February 6, 2018.
Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I
Document Number: 2019-07460
Type: Rule
Date: 2019-04-16
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic cannabinoids (SC), ethyl 2-(1-(5-fluoropentyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate (trivial name: 5F-EDMB- PINACA); methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate (trivial name: 5F-MDMB-PICA); N-(adamantan-1-yl)-1- (4-fluorobenzyl)-1H-indazole-3-carboxamide (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)); 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial names: 5F-CUMYL- PINACA; SGT-25); and (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone (trivial name: FUB-144), and their optical, positional, and geometric isomers, salts, and salts of isomers in schedule I. This action is based on a finding by the Acting Administrator that the placement of these SCs in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB- AKB48, 5F-CUMYL-PINACA or FUB-144.
Importer of Controlled Substances Application: Sanyal Biotechnology, LLC
Document Number: 2019-06854
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I
Document Number: 2019-06853
Type: Proposed Rule
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing methyl 2- (1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbu tanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate [5F-AMB]; N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide [5F-APINACA, 5F-AKB48]; N-(1- amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-ind azole-3- carboxamide [ADB-FUBINACA]; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate [MDMB-FUBINACA], including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA.
Importer of Controlled Substances Application: SpecGx LLC
Document Number: 2019-06852
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I of the Controlled Substances Act
Document Number: 2019-06851
Type: Rule
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of six synthetic cannabinoids (SC). The substances are: methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2- (1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutano ate [5F- AMB]; N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxami de [5F-APINACA, 5F-AKB48]; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA]; methyl 2-(1- (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutan oate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA], including their optical, positional and geometric isomers, salts, and salts of isomers. The schedule I status of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA will expire on April 10, 2019. This temporary order will extend the temporary scheduling of 5F- ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA for one year or until the permanent scheduling action for these six substances is completed, whichever occurs first.
Importer of Controlled Substances Application: Unither Manufacturing LLC
Document Number: 2019-06850
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Document Number: 2019-06849
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-06848
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of various classes of schedule I controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06847
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of schedule I controlled substances.
Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC
Document Number: 2019-06846
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2019-06845
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of a schedule I controlled substance.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-06844
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06843
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as an importer of schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06842
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Martin A. Barrios, M.D.; Decision and Order
Document Number: 2019-06836
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Richard Carter, M.D.; Decision and Order
Document Number: 2019-06835
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Craig M. Weingrow, M.D.; Decision and Order
Document Number: 2019-06834
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
Document Number: 2019-05392
Type: Notice
Date: 2019-03-21
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2019-05389
Type: Notice
Date: 2019-03-21
Agency: Drug Enforcement Administration, Department of Justice
William A. Sanpablo, M.D.; Decision and Order
Document Number: 2019-05014
Type: Notice
Date: 2019-03-18
Agency: Drug Enforcement Administration, Department of Justice
Joel A. Smithers, D.O.; Decision and Order
Document Number: 2019-05013
Type: Notice
Date: 2019-03-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Sharp (Bethlehem), LLC
Document Number: 2019-05000
Type: Notice
Date: 2019-03-18
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-04033
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of schedule I or schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-04032
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of schedule I controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-04031
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as bulk manufacturer of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: S&B Pharma Inc.
Document Number: 2019-04030
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc.
Document Number: 2019-04029
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-04027
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-04026
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by-the Drug Enforcement Administration (DEA) as an importer of schedule I controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-04025
Type: Notice
Date: 2019-03-06
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Document Number: 2019-03689
Type: Notice
Date: 2019-03-01
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Meridian Medical Technologies
Document Number: 2019-03688
Type: Notice
Date: 2019-03-01
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.
Document Number: 2019-02883
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc.
Document Number: 2019-02882
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Document Number: 2019-02881
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Document Number: 2019-02878
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Document Number: 2019-02877
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222)
Document Number: 2019-02875
Type: Proposed Rule
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is proposing to amend its regulations to implement a new single-sheet format for order forms (DEA Form 222) which are issued by DEA to DEA registrants to allow them to order schedule I and/or II controlled substances. DEA published a notice of proposed rulemaking about this new format in November 2007 but did not finalize it. Due to the passage of time and procedural considerations, DEA is reissuing another notice of proposed rulemaking. This proposal supersedes the November 2007 proposal. This proposed rule calls for allowing the continued use of the existing triplicate DEA Form 222 until a sunset date of two years after the final rule becomes effective, which would be included in the final rule. DEA also proposes minor procedural changes, including among other things, to clarify the procedure involving who can issue the power of attorney that is required for others to sign DEA Form 222.
Importer of Controlled Substances Registration
Document Number: 2019-02874
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-02871
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-02870
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted registration by the Drug Enforcement Administration (DEA) as an importer of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-02869
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.